Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

Affiliations

¹ Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium.
² Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
³ Laboratory of Cell Stress and Immunity (CSI), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
⁴ Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
⁵ Department of Urology, University Hospitals Leuven, Leuven, Belgium.
⁶ Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.
⁷ Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
⁸ VIB Center for Cancer Biology, VIB, Leuven, Belgium.
⁹ JJP Biologics, Warsaw, Poland.
¹⁰ Histocompatibility and Immunogenetics Laboratory, Belgian Red Cross-Flanders, Mechelen, Belgium.
¹¹ Inserm, UMRS-1138, Génomique fonctionnelle des tumeurs solides, Centre de recherche des Cordeliers, Paris, France.
¹² Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
¹³ Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. benoit.beuselinck@uzleuven.be.
¹⁴ Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. benoit.beuselinck@uzleuven.be.
¹⁵ Laboratory of Cell Stress and Immunity (CSI), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. abhishek.garg@kuleuven.be.

^# Contributed equally.

Published Erratum

Lisa Kinget et al. Nat Med. 2024 Aug.

. 2024 Aug;30(8):2375-2376.

doi: 10.1038/s41591-024-03174-5.

¹ Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium.
² Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
³ Laboratory of Cell Stress and Immunity (CSI), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
⁴ Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
⁵ Department of Urology, University Hospitals Leuven, Leuven, Belgium.
⁶ Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.
⁷ Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
⁸ VIB Center for Cancer Biology, VIB, Leuven, Belgium.
⁹ JJP Biologics, Warsaw, Poland.
¹⁰ Histocompatibility and Immunogenetics Laboratory, Belgian Red Cross-Flanders, Mechelen, Belgium.
¹¹ Inserm, UMRS-1138, Génomique fonctionnelle des tumeurs solides, Centre de recherche des Cordeliers, Paris, France.
¹² Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
¹³ Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. benoit.beuselinck@uzleuven.be.
¹⁴ Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. benoit.beuselinck@uzleuven.be.
¹⁵ Laboratory of Cell Stress and Immunity (CSI), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. abhishek.garg@kuleuven.be.

^# Contributed equally.

No abstract available

Erratum for

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.
Kinget L, Naulaerts S, Govaerts J, Vanmeerbeek I, Sprooten J, Laureano RS, Dubroja N, Shankar G, Bosisio FM, Roussel E, Verbiest A, Finotello F, Ausserhofer M, Lambrechts D, Boeckx B, Wozniak A, Boon L, Kerkhofs J, Zucman-Rossi J, Albersen M, Baldewijns M, Beuselinck B, Garg AD. Kinget L, et al. Nat Med. 2024 Jun;30(6):1667-1679. doi: 10.1038/s41591-024-02978-9. Epub 2024 May 21. Nat Med. 2024. PMID: 38773341